1. Department of Neurology, Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario, Málaga, Spain
2. Department of Pharmacology, Faculty of Medicine, University of Malaga, Malaga, Spain
3. Unidad de Esclerosis Múltiple, Hospital Universitario Virgen Macarena, Sevilla, Spain
4. Neurología, Hospital Universitario Reina Sofía – IMIBIC, Córdoba, Spain
5. Departamento de Neurociencias, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
6. Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain
7. Novartis Pharma AG, Basel, Switzerland
8. Novartis Pharmaceuticals Australia, NSW, Australia
9. MS and Neuroimmunology Unit, Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia